CATO SMS, formed by the merger of CATO Research and SMS-oncology, is a team that will tackle your toughest challenges with confidence and precision. With more than 30 years of global experience, our team is optimized for small and emerging biopharma sponsors like you. With offices across North America, Europe, and the Middle East, CATO SMS has experience conducting trials in more than 25 countries.
Our specialists deliver innovative regulatory consulting solutions to guide you through the most complex regulatory challenges. Our expert teams effectively design and execute clinical trials — from strategy to approval — in complex indications and modalities across a variety of therapeutic areas, with a proven center of excellence in oncology.
Our combination of regulatory, therapeutic, and operational expertise enables us to meet your challenges and seize opportunities that arise before or during study conduct. Whether you need experts in medical affairs, regulatory consulting services, or clinical trial management, we can help you meet your goals.
CATO SMS nurtures a high-performance culture in which we provide continuous training and put emphasis on personal and organizational development and opportunities, anchored by a commitment to high quality and personalized customer service. We consider effective, frequent, and open communication as a key component to developing strategies to meet your needs and goals. We provide lean project management to accomplish operational excellence in terms of timelines, quality, and costs. Our motivating culture is represented by our industry leading retention rate that clearly distinguishes CATO SMS.
- Over 750 regulatory submissions a year
- Over 500 clinical trials conducted
- Over 5,500 clinical trial sites included
- Over 60,000 patients enrolled
- Over 25 countries participated in monitored and managed clinical studies